23
Participants
Start Date
May 16, 2016
Primary Completion Date
January 25, 2022
Study Completion Date
January 25, 2022
Pevonedistat 25 mg/m^2
Pevonedistat 25 mg/m\^2 intravenous infusion.
Pevonedistat 44 mg/m^2
Pevonedistat 44 mg/m\^2 intravenous infusion.
Pevonedistat 10 mg/m^2
Pevonedistat 10 mg/m\^2 intravenous infusion.
Pevonedistat 20 mg/m^2
Pevonedistat 20 mg/m\^2 intravenous infusion.
Azacitidine 75 mg/m^2
Azacitidine 75 mg/m\^2 intravenous or subcutaneous formulation.
Taipei Veterans General Hospital, Taipei
National Taiwan University Hospital, Taipei
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul
Maebashi
Nagoya
Sendai
Tokyo
Chonnam National University Hwasun Hospital, Jeonnam
Severance Hospital Yonsei University Health System - PPDS, Seoul
Lead Sponsor
Millennium Pharmaceuticals, Inc.
INDUSTRY